Inventor · disambiguated record
Adrian Hayday
Also filed as: HAYDAY ADRIAN · HAYDAY ADRIAN C
15 granted patents·14 pending applications·24 citations·filing 2003–2024
89Inventor score
Files withIMMUNOQURE AG9KING S COLLEGE LONDON8TRANSIMMUNE AG6CANCER RESEARCH TECH LTD2GAMMADELTA THERAPEUTICS LTD2
Top patents by PatentIndex Score
29 records- 0187US10131709B2Nucleic acid molecules encoding monoclonal antibodies specific for IL-22IMMUNOQURE AG·Filed 2016·Granted Nov 20, 2018·4 cites·21 claims
- 0283US10081676B2Human anti-IL-32 antibodies and methods of making and using the sameIMMUNOQURE AG·Filed 2014·Granted Sep 25, 2018·4 cites·35 claims
- 0380US9475872B2Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17FIMMUNOQURE AG·Filed 2013·Granted Oct 25, 2016·5 cites·22 claims
- 0479US11179417B2Method for obtaining globally activated monocytesTRANSIMMUNE AG·Filed 2015·Granted Nov 23, 2021·2 cites·5 claims
- 0579US10112995B2Human anti-IFN-α antibodiesIMMUNOQURE AG·Filed 2014·Granted Oct 30, 2018·4 cites·34 claims
- 0676US9957319B2Method of isolating human antibodiesIMMUNOQURE AG·Filed 2013·Granted May 1, 2018·3 cites·14 claims
- 0773US10941198B2Human anti-IFN-α antibodiesIMMUNOQURE AG·Filed 2018·Granted Mar 9, 2021·1 cites·30 claims
- 0870US12458698B2Expansion of γδ T cells, compositions, and methods of use thereofKING S COLLEGE LONDON·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 0968US11945861B2Human anti-IFN-α antibodiesIMMUNOQURE AG·Filed 2021·Granted Apr 2, 2024·0 cites·23 claims
- 1068US11655453B2Expansion of γδ T cells, compositions, and methods of use thereofKING S COLLEGE LONDON·Filed 2018·Granted May 23, 2023·1 cites·17 claims
- 1167US12364755B2Method for obtaining globally activated monocytesTRANSIMMUNE AG·Filed 2021·Granted Jul 22, 2025·0 cites·13 claims
- 1264US2024131191A1Compositions and methods for enhancing gamma delta t cells in the gutKING S COLLEGE LONDON·Filed 2023·Application pending·0 cites
- 1364US2024123090A1Compositions and methods for enhancing gamma delta t cells in the gutKING S COLLEGE LONDON·Filed 2023·Application pending·0 cites
- 1464US2025122264A1Btnl3/8 targeting constructs for delivery of payloads to the gastrointestinal systemKING S COLLEGE LONDON·Filed 2024·Application pending·0 cites
- 1564US2023099491A1Expansion of non-haematopoietic tissue-resident gamma delta t cells and uses of these cellsCANCER RESEARCH TECH LTD·Filed 2022·Application pending·0 cites
- 1662US10875916B2Nucleic acid molecules encoding monoclonal antibodies specific for IL-17FIMMUNOQURE AG·Filed 2018·Granted Dec 29, 2020·0 cites·24 claims
- 1761US2024400990A1Immune cell populations and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1860US2022259556A1Method for obtaining immuno-suppressive dendritic cellsTRANSIMMUNE AG·Filed 2021·Application pending·0 cites
- 1960US2022112462A1Method for obtaining immuno-stimulatory dendritic cellsTRANSIMMUNE AG·Filed 2021·Application pending·0 cites
- 2056US12152064B2BTNL3/8 targeting constructs for delivery of payloadsKING S COLLEGE LONDON·Filed 2019·Granted Nov 26, 2024·0 cites·15 claims
- 2154US10975144B2CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibodyIMMUNOQURE AG·Filed 2018·Granted Apr 13, 2021·0 cites·20 claims
- 2254US2009317457A1Anti-inflammatory and wound healing effects of lymphoid thymosin b-4UNIV YALE·Filed 2009·Application pending·0 cites
- 2352US2020297871A1Compositions and methods for enhancing gamma delta t cells in the gutKING S COLLEGE LONDON·Filed 2018·Application pending·0 cites
- 2451US2006264360A1Anti-inflammatory and wound healing effects of lymphoid thymosin beta-4KING S COLLEGE LONDON·Filed 2003·Application pending·0 cites
- 2550US2023159638A1Ex vivo gamma delta t cell populationsGAMMADELTA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2650US2023090901A1Novel antibodiesGAMMADELTA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2750US2016298082A1Method for obtaining immuno-stimulatory dendritic cellsTRANSIMMUNE AG·Filed 2014·Application pending·0 cites
- 2848US11618885B2Expansion of non-haematopoietic tissue-resident gamma delta T cells and uses of these cellsCANCER RESEARCH TECH LTD·Filed 2016·Granted Apr 4, 2023·0 cites·14 claims
- 2945US2016130552A1Method for obtaining immuno-suppressive dendritic cellsTRANSIMMUNE AG·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adrian Hayday files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →